Metropolis Healthcare, a company in the Healthcare Service Provider industry, reported revenue of ₹497 crore and net profit of ₹75 crore for the September 2026 quarter.
Metropolis Healthcare (NSE: METROPOLIS) closed at ₹566.00 on 20 Nov 2026, up 15.5% over the past year. Its market capitalisation is ₹11,746 crore and it trades at 50.9 times earnings.
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.